| | COMPOUND: C07514 | |
Entry |
|
Name |
|
Formula |
C9H13N
|
Exact mass |
135.1048
|
Mol weight |
135.2062
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA01 Amfetamine
D07445 Amfetamine (INN) <US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Attention Deficit Hyperactivity Disorder Agents, Amphetamines
Amphetamine
D07445 Amfetamine (INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00966 Amfetamine
D07445 Amfetamine
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D07445 Amfetamine (INN) <US>
SLC6A3 (DAT1)
D07445 Amfetamine (INN) <US>
SLC18
SLC18A2 (VMAT2)
D07445 Amfetamine (INN) <US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D07445
Prodrugs [br08324.html]
D07445
Narcotics and psychotropics in Japan [br08308.html]
Stimulants by Control Act Article 2 Appended Table and Cabinet Order
D07445
Prodrugs [br08324.html]
C07514
|
Other DBs |
|
KCF data |
ATOM 10
1 C8y C 17.9984 -15.2668
2 C8x C 16.8020 -14.5631
3 C8x C 17.9984 -16.6744
4 C1b C 19.2652 -14.5631
5 C8x C 15.6056 -15.2668
6 C8x C 16.8020 -17.3781
7 C1c C 20.4616 -15.2668
8 C8x C 15.6056 -16.6744
9 N1a N 21.6580 -14.5631
10 C1a C 20.4616 -16.6744
BOND 10
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 7 9 1
9 7 10 1
10 6 8 1
|
|
» Japanese version
|
|